Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of GBP 21.52 million. The enterprise value is -7.14 million.

Market Cap	21.52M
Enterprise Value	-7.14M

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.06%
Shares Change (QoQ)	+1.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.23
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.36

Financial Position

The company has a current ratio of 6.92, with a Debt / Equity ratio of 0.04.

Current Ratio	6.92
Quick Ratio	6.53
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.57% and return on invested capital (ROIC) is -29.64%.

Return on Equity (ROE)	-50.57%
Return on Assets (ROA)	-27.61%
Return on Capital (ROIC)	-29.64%
Revenue Per Employee	35,240
Profits Per Employee	-198,724
Employee Count	155
Asset Turnover	0.08
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.28%
50-Day Moving Average	0.88
200-Day Moving Average	1.16
Relative Strength Index (RSI)	47.19
Average Volume (20 Days)	6,970

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.69

Income Statement

In the last 12 months, Co-Diagnostics had revenue of GBP 5.46 million and -30.80 million in losses. Loss per share was -1.03.

Revenue	5.46M
Gross Profit	2.69M
Operating Income	-29.84M
Pretax Income	-27.89M
Net Income	-30.80M
EBITDA	-28.85M
EBIT	-29.84M
Loss Per Share	-1.03

Full Income Statement

Balance Sheet

The company has 28.10 million in cash and 1.77 million in debt, giving a net cash position of 26.33 million.

Cash & Cash Equivalents	28.10M
Total Debt	1.77M
Net Cash	26.33M
Net Cash Per Share	n/a
Equity (Book Value)	47.59M
Book Value Per Share	1.49
Working Capital	25.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.18 million and capital expenditures -850,529, giving a free cash flow of -20.03 million.

Operating Cash Flow	-19.18M
Capital Expenditures	-850,529
Free Cash Flow	-20.03M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	49.30%
Operating Margin	-546.37%
Pretax Margin	-510.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.06%
Shareholder Yield	-2.06%
Earnings Yield	-143.15%
FCF Yield	-93.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Co-Diagnostics has an Altman Z-Score of 1.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.07
Piotroski F-Score	n/a